 |
PDBsum entry 1qgf
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Hydrolase
|
 |
|
Title:
|
 |
Porcine pancreatic elastase complexed with (3r, 4s)n-para- toluenesulphonyl-3-ethyl-4-(carboxylic acid)pyrrolidin-2-one
|
|
Structure:
|
 |
Elastase. Chain: a. Synonym: ppe (porcine pancreatic elastase). Ec: 3.4.21.36
|
|
Source:
|
 |
Sus scrofa. Pig. Organism_taxid: 9823. Organ: pancreas
|
|
Resolution:
|
 |
|
1.70Å
|
R-factor:
|
0.183
|
R-free:
|
0.210
|
|
|
Authors:
|
 |
R.C.Wilmouth,S.Kassamally,N.J.Westwood,R.J.Sheppard,T.D.W.Claridge, P.A.Wright,G.J.Pritchard,C.J.Schofield
|
Key ref:
|
 |
R.C.Wilmouth
et al.
(1999).
Mechanistic insights into the inhibition of serine proteases by monocyclic lactams.
Biochemistry,
38,
7989-7998.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
27-Apr-99
|
Release date:
|
29-Dec-99
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
P00772
(CELA1_PIG) -
Chymotrypsin-like elastase family member 1 from Sus scrofa
|
|
|
|
Seq: Struc:
|
 |
 |
 |
266 a.a.
240 a.a.*
|
|
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
*
PDB and UniProt seqs differ
at 1 residue position (black
cross)
|
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.3.4.21.36
- pancreatic elastase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
Hydrolysis of proteins, including elastin. Preferential cleavage: Ala-|-Xaa.
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Biochemistry
38:7989-7998
(1999)
|
|
PubMed id:
|
|
|
|
|
| |
|
Mechanistic insights into the inhibition of serine proteases by monocyclic lactams.
|
|
R.C.Wilmouth,
S.Kassamally,
N.J.Westwood,
R.J.Sheppard,
T.D.Claridge,
R.T.Aplin,
P.A.Wright,
G.J.Pritchard,
C.J.Schofield.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Although originally discovered as inhibitors of pencillin-binding proteins,
beta-lactams have more recently found utility as serine protease inhibitors.
Indeed through their ability to react irreversibly with nucleophilic serine
residues they have proved extraordinarily successful as enzyme inhibitors.
Consequently there has been much speculation as to the reason for the general
effectiveness of beta-lactams as antibacterials or inhibitors of hydrolytic
enzymes. The interaction of analogous beta- and gamma-lactams with a serine
protease was investigated. Three series of gamma-lactams based upon monocyclic
beta-lactam inhibitors of elastase [Firestone, R. A. et al. (1990) Tetrahedron
46, 2255-2262.] but with an extra methylene group inserted between three of the
bonds in the ring were synthesized. Their interaction with porcine pancreatic
elastase and their efficacy as inhibitors were evaluated through the use of
kinetic, NMR, mass spectrometric, and X-ray crystallographic analyses. The first
series, with the methylene group inserted between C-3 and C-4 of the beta-lactam
template, were readily hydrolyzed but were inactive or very weakly active as
inhibitors. The second series, with the methylene group between C-4 and the
nitrogen of the beta-lactam template, were inhibitory and reacted reversibly
with PPE to form acyl-enzyme complexes, which were stable with respect to
hydrolysis. The third series, with the methylene group inserted between C-2 and
C-3, were not hydrolyzed and were not inhibitors consistent with lack of binding
to PPE. Comparison of the crystal structure of the acyl-enzyme complex formed
between PPE and a second series gamma-lactam and that formed between PPE and a
peptide [Wilmouth, R. C., et al. (1997) Nat. Struct. Biol. 4, 456-462.] reveals
why the complexes formed with this series were resistant to hydrolysis and
suggests ways in which stable acyl-enzyme complexes might be obtained from
monocyclic gamma-lactam-based inhibitors.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
P.Singh,
S.A.Williams,
M.H.Shah,
T.Lectka,
G.J.Pritchard,
J.T.Isaacs,
and
S.R.Denmeade
(2008).
Mechanistic insights into the inhibition of prostate specific antigen by beta-lactam class compounds.
|
| |
Proteins,
70,
1416-1428.
|
 |
|
|
|
|
 |
P.Macheboeuf,
D.S.Fischer,
T.Brown,
A.Zervosen,
A.Luxen,
B.Joris,
A.Dessen,
and
C.J.Schofield
(2007).
Structural and mechanistic basis of penicillin-binding protein inhibition by lactivicins.
|
| |
Nat Chem Biol,
3,
565-569.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
R.Villar,
M.J.Gil,
J.I.García,
and
V.Martínez-Merino
(2005).
Are AM1 ligand-protein binding enthalpies good enough for use in the rational design of new drugs?
|
| |
J Comput Chem,
26,
1347-1358.
|
 |
|
|
|
|
 |
P.Kulanthaivel,
A.J.Kreuzman,
M.A.Strege,
M.D.Belvo,
T.A.Smitka,
M.Clemens,
J.R.Swartling,
K.L.Minton,
F.Zheng,
E.L.Angleton,
D.Mullen,
L.N.Jungheim,
V.J.Klimkowski,
T.I.Nicas,
R.C.Thompson,
and
S.B.Peng
(2004).
Novel lipoglycopeptides as inhibitors of bacterial signal peptidase I.
|
| |
J Biol Chem,
279,
36250-36258.
|
 |
|
|
|
|
 |
M.A.McDonough,
and
C.J.Schofield
(2003).
New structural insights into the inhibition of serine proteases by cyclic peptides from bacteria.
|
| |
Chem Biol,
10,
898-900.
|
 |
|
|
|
|
 |
M.Paetzel,
R.E.Dalbey,
and
N.C.Strynadka
(2000).
The structure and mechanism of bacterial type I signal peptidases. A novel antibiotic target.
|
| |
Pharmacol Ther,
87,
27-49.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
');
}
}
 |